Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
As we enter the full swing of the fall run in Western Canada, beef cattle producers need to think about the right time to ...
HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback